Home » Home

Qwince

Cardiocity are pleased to announce a new supply partnership with Qwince/Securproject Italy. The partnership has already seen SecureIT deploy multiple RhythmPad systems to the University Hospital in Ferrara and follows on from a period of demonstration and software developments.

Read more
valeroyal

Cardiocity will be attending the South Cheshire and Vale Royal GP Alliance Expo, demonstrating the RhythmPad range of products and showing how the technology solves many common problems for GP’s, CCG’s and Mental Health professionals alike. Having worked with the GP Alliance to procure en mass, Cardiocity continues their programme of works to support GP’s …

Read more
2ccg

Cardiocity has agreed a dual CCG wide roll out of RhythmPadGP units in the Cheshire region. The deal will see GP surgeries issued with Cardiocity’s RhythmPadGP systems connected into their Electronic Patient Records with the intention of mass screening patients for cardiac arrhythmia. The deal, which was led by Vale Royal and South Cheshire GP …

Read more
nice_logo

Cardiocity are delighted to have been approached by the National Institue for Health and Clinical Excellence with regards the evaluation of the performance of the RhythmPadGP system. Following great introduction into the UK NHS market, the RhythmPadGP provides the only UK manufactured system that provides reliable single and 6 lead ECG analysis. Cardiocity are pleased …

Read more
ace

Cardiocity are delighted to hear that ¬†AntiCoagulation Europe has won the Global Health and Pharma Social Care Award for Best Anticoagulant Support Charity UK 2017. Cardiocity are keen supporters of ACE’s work and have been partnering with the charity over the last few years on a number of initiative. Cardiocity’s Chris Crockford commented: “Being FactorV …

Read more
medica_easme_2016_2

Cardiocity have been working flat out since the start of 2017 to send out RhythmPad’s to interested GP’s, Practice Nurses and HCA’s across NHS England. We will be restarting bulk manufacture with our partners in Northern Ireland in February. Cardiocity have also been invited to work on the development of kiosk based systems for NHS …

Read more
congress

Cardiocity’s RhythmPad has completed another NIHR accredited clinical trial and provided an accuracy of 97% with regards comparison blinded analysis of a Gold Standard 12 lead with the RhythmPad’s 6 lead output. The trial, conducted on 752 patients, which was undertaken at St Peter’s Hospital in Chertsey, Surrey, UK concluded a sensitivity and specificity of …

Read more
RhythmPad-Kiosk-2

Cardiocity’s UK wide NHS England demonstrator known as “Safe2Screen” has passed 40,000 people screened for cardiac arrhythmia. The Kiosks which are located from Lancashire across the country to Kent, work on a voluntary basis with people opting to screen themselves for cardiac arrhythmias whilst waiting to see their GP. Cardiocity’s founder Chris Crockford commented “We …

Read more
Expo

Cardiocity Limited were delighted to be invited to attend the NHS Innovations Expo by Kent Surrey Sussex AHSN. KSS who featured Cardiocity’s ground breaking RhythmPad Kiosks AF screening systems in their Spring Issue of their in house “Innovate” magazine invited Cardiocity to attend and to bring them up to speed with regards the achievements of …

Read more
DSC_0025

Cardiocity have met with EMIS with regards the implementation of the RhythmPadGP and RhythmPadKiosk systems with the EMIS Electronic Patient Record system. EMIS currently have the market share of the UK GP Electronic Patient Record system and being able to integrate the RhythmPad’s cardiac analysis data directly into the patient record has long been Cardiocity’s …

Read more
Page 1 of 3123